Page 2 - Best Immunotherapy for lung cancer doctors: TOP 45 doctors

Professor Cemil Bilir brings over 21 years of experience of specialized experience in lung cancer immunotherapy at VM Medical Park Pendik Hospital.

• Board-certified in medical oncology with additional training at Cleveland Clinic
• Active member of ASCO and ESMO – stays current with latest protocols
• Currently pursuing Ph.D. in inorganic chemistry to enhance treatment approaches
• Teaches medical oncology at Sakarya University Faculty of Medicine

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor of Medical Oncology at Trakya University – specializes in immunotherapy for lung cancer at İstinye University Liv Hospital Topkapı.

• 29 years of experience of experience in medical oncology
• Fellowship-trained in Medical Oncology from Trakya University
• Former Associate Professor and current Professor at Trakya University
• Military service experience at Turkish Air Force Command Hospital

Dr. Ozden specializes in medical oncology with extensive training in immunotherapy for lung cancer at Kocaeli University.

• Over 27 years of experience of experience in internal medicine and oncology
• Completed medical oncology subspecialty at Kocaeli University
• Graduated from Istanbul University's prestigious Cerrahpaşa Faculty of Medicine
• Practices at VM Medical Park Pendik Hospital

Specializes in immunotherapy for lung cancer at Medical Park Antalya Hospital Complex – trained at Akdeniz University, a leader in oncology.

• Board-certified in medical oncology with 20 years of experience of experience
• Extensive training at Akdeniz University, a top Turkish medical school
• Works with advanced immunotherapy protocols for lung cancer
• Member of the Turkish Medical Oncology Association

Assoc. Prof. Atakan Topcu specializes in immunotherapy for lung cancer at Medipol Acibadem District Hospital, with over 50 published scientific articles.

• Expert in targeted therapies and immunotherapy for solid tumors
• Member of European Society for Medical Oncology (ESMO)
• Fellowship-trained in Medical Oncology at Bezmialem Vakıf University
• Editorial Board Member for BMC Cancer journal

Assoc. Prof. Nail Paksoy specializes in immunotherapy for lung cancer at Medipol Bahçelievler Hospital, with extensive research and clinical trial experience.

• ESMO Board Certified in Medical Oncology
• Subinvestigator in multiple international lung cancer immunotherapy trials
• Published research on novel treatments for NSCLC
• Fellowship-trained in Medical Oncology at Istanbul University

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Leading expert in immunotherapy for lung cancer – Dr. Felip integrates novel immunotherapies into treatment protocols at Hospital Quiron Barcelona.

• Current member of ESMO, ASCO, and IASLC
• Received the ESMO Women for Oncology Award in 2015
• Co-chair of the 20th WCLC Congress in Barcelona
• Professor of Medicine at Universitat de Vic

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Assoc. Prof. Ayse Irem Yasin specializes in immunotherapy for lung cancer at Medipol Acibadem District Hospital.

• Holds an ESMO Board Certificate – a mark of excellence in oncology
• Trained at top institutions including Cleveland Clinic and Harvard Medical School
• Fellowship in Medical Oncology from Bezmialem Vakif University
• Experienced in treating various cancers including lung and breast

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı – specializes in lung cancer immunotherapy with research published in peer-reviewed journals.

• Member of American Society of Clinical Oncology (ASCO) since 2018
• Published multiple studies on lung cancer treatment outcomes
• Education Coordinator for Medical Oncology Sub-Branch
• Residency in Internal Medicine at Istanbul Şişli Hamidiye Etfal Health Application and Research Center

Dr. Shaikh specializes in oral cancer surgeries and rehabilitation at HCG Manavata Cancer Centre in Nashik.

• 15 years of experience of experience in surgical oncology
• Expertise in organ preservation and functional rehabilitation for oral cancer patients
• Proficient in major maxillofacial and head & neck surgeries
• Fellowship-trained in Head & Neck Surgical Oncology
• Published researcher in the field

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries – 30 years of experience of surgical oncology expertise focused on thoracic oncology.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• Involved in 200+ immunotherapy clinical trials
• Professor for DNB Superspecialty Surgical Oncology
• Author of multiple international and national publications

Dr. Shaunak specializes in immunotherapy for lung cancer, with a strong focus on molecular-based treatments and targeted therapies.

• Trained in Medical Oncology at Indraprastha Apollo Hospital
• Presented research on stomach cancer at ASCO symposium
• Expertise in molecular basis of cancer
• Senior Residency in Internal Medicine

Specializing in minimally invasive cancer surgeries with excellent outcomes – Dr. Banswal has successfully performed over 10,000 major surgeries.

• 15 years of experience of surgical oncology experience
• Trained in gastrointestinal cancer at Tata Medical Centre
• Assistant Professor at State Cancer Institute
• Multiple national and international publications